Format

Send to

Choose Destination
Aesthetic Plast Surg. 2007 Sep-Oct;31(5):468-92; discussion 493-4. Epub 2007 Jun 18.

Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods.

Author information

1
Division Plastic and Reconstructive Surgery, American University of Beirut Medical Center, Beirut, Lebanon. aata@terra.net.lb

Abstract

Hypertrophic scars, resulting from alterations in the normal processes of cutaneous wound healing, are characterized by proliferation of dermal tissue with excessive deposition of fibroblast-derived extracellular matrix proteins, especially collagen, over long periods, and by persistent inflammation and fibrosis. Hypertrophic scars are among the most common and frustrating problems after injury. As current aesthetic surgical techniques become more standardized and results more predictable, a fine scar may be the demarcating line between acceptable and unacceptable aesthetic results. However, hypertrophic scars remain notoriously difficult to eradicate because of the high recurrence rates and the incidence of side effects associated with available treatment methods. This review explores the various treatment methods for hypertrophic scarring described in the literature including evidence-based therapies, standard practices, and emerging methods, attempting to distinguish those with clearly proven efficiency from anecdotal reports about therapies of doubtful benefits while trying to differentiate between prophylactic measures and actual treatment methods. Unfortunately, the distinction between hypertrophic scar treatments and keloid treatments is not obvious in most reports, making it difficult to assess the efficacy of hypertrophic scar treatment.

PMID:
17576505
DOI:
10.1007/s00266-006-0253-y
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center